Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spector

Showing results (901-910 of 939) with videos related to

Pageof 94
Sort By:
The Journal of Infectious Diseases|December 26, 2001
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapyJ L Lathey, C Tierney, S Y Chang, et al.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
Cardiovascular Research|March 16, 2021
Targeting angiotensin type-2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in miceMazher Mohammed, Dominique N Johnson, Lei A Wang, et al.
Journal of the American Heart Association|May 24, 2017
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) TrialJason V Baker, Shweta Sharma, Amit C Achhra, et al.
Infectious Disorders Drug Targets|January 28, 2012
Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat proteinSonia Mediouni, Albert Darque, Gilbert Baillat, et al.
AIDS (London, England)|February 15, 2021
Longitudinal changes in epigenetic age in youth with perinatally acquired HIV and youth who are perinatally HIV-exposed uninfectedStephanie Shiau, Sean S Brummel, Elizabeth M Kennedy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2017
Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected ChildrenDenise L Jacobson, Charles B Stephensen, Tracie L Miller, et al.
The Journal of Allergy and Clinical Immunology|November 12, 2003
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 studyWilliam T Shearer, Howard M Rosenblatt, Rebecca S Gelman, et al.
HIV Medicine|March 28, 2008
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokineticsE V Capparelli, F Aweeka, J Hitti, et al.
The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.
Pageof 94

Showing results (901-910 of 939) with videos related to

Sort By:
Pageof 94
The Journal of Infectious Diseases|December 26, 2001
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapyJ L Lathey, C Tierney, S Y Chang, et al.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
Cardiovascular Research|March 16, 2021
Targeting angiotensin type-2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in miceMazher Mohammed, Dominique N Johnson, Lei A Wang, et al.
Journal of the American Heart Association|May 24, 2017
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) TrialJason V Baker, Shweta Sharma, Amit C Achhra, et al.
Infectious Disorders Drug Targets|January 28, 2012
Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat proteinSonia Mediouni, Albert Darque, Gilbert Baillat, et al.
AIDS (London, England)|February 15, 2021
Longitudinal changes in epigenetic age in youth with perinatally acquired HIV and youth who are perinatally HIV-exposed uninfectedStephanie Shiau, Sean S Brummel, Elizabeth M Kennedy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2017
Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected ChildrenDenise L Jacobson, Charles B Stephensen, Tracie L Miller, et al.
The Journal of Allergy and Clinical Immunology|November 12, 2003
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 studyWilliam T Shearer, Howard M Rosenblatt, Rebecca S Gelman, et al.
HIV Medicine|March 28, 2008
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokineticsE V Capparelli, F Aweeka, J Hitti, et al.
The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.
Pageof 94